A Study Of Dazostinag As Single Agent And Dazostinag In Combination With Pembrolizumab In Adults With Advanced Or Metastatic Solid Tumors (IIntune-1)
Posted Date: Apr 26, 2024
- Investigator: Davendra Sohal
- Specialties: Colorectal Cancer, Head and Neck Cancer
- Type of Study: Drug
The main aim of this study is to check if people with advanced solid tumors have side effects from dazostinag, and to check how much dazostinag they can receive without getting significant side effects from it when given alone and in combination with pembrolizumab.
Criteria:
Null
Keywords:
Solid Tumors
For More Information:
Kayla Webb
NULL
cancer@uchealth.com